These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23292524)

  • 1. Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study.
    Chia A; Li W; Tan D; Luu CD
    Doc Ophthalmol; 2013 Jun; 126(3):177-86. PubMed ID: 23292524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal electroretinogram in children on atropine treatment for myopia.
    Luu CD; Lau AM; Koh AH; Tan D
    Br J Ophthalmol; 2005 Feb; 89(2):151-3. PubMed ID: 15665343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
    Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
    Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report.
    Zhang XJ; Zhang Y; Yip BHK; Kam KW; Tang F; Ling X; Ng MPH; Young AL; Wu PC; Tham CC; Chen LJ; Pang CP; Yam JC
    Ophthalmology; 2024 Sep; 131(9):1011-1020. PubMed ID: 38494130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute effect of atropine eye drops on the human full-field electroretinogram.
    Khanal S; Rathod SN; Phillips JR
    Doc Ophthalmol; 2021 Jun; 142(3):315-328. PubMed ID: 33231734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Various Concentrations of Low-Dose Atropine on Pupillary Diameter and Accommodative Amplitude in Children with Myopia.
    Tran HDM; Ha TTX; Tran YH; Coroneo M; Tran TD; Truong TU; Sankaridurg P
    J Ocul Pharmacol Ther; 2024 May; 40(4):232-239. PubMed ID: 38621178
    [No Abstract]   [Full Text] [Related]  

  • 7. Little effect of 0.01% atropine eye drops as used in myopia prevention on the pattern electroretinogram.
    Anders LM; Heinrich SP; Lagrèze WA; Joachimsen L
    Doc Ophthalmol; 2019 Apr; 138(2):85-95. PubMed ID: 30680489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myopia Control in Caucasian Children with 0.01% Atropine Eye Drops: 1-Year Follow-Up Study.
    Simonaviciute D; Gelzinis A; Kapitanovaite L; Grzybowski A; Zemaitiene R
    Medicina (Kaunas); 2024 Jun; 60(7):. PubMed ID: 39064451
    [No Abstract]   [Full Text] [Related]  

  • 9. Additive effect of atropine eye drops and short-term retinal defocus on choroidal thickness in children with myopia.
    Chiang ST; Turnbull PRK; Phillips JR
    Sci Rep; 2020 Oct; 10(1):18310. PubMed ID: 33110130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric norms for photopic electroretinogram testing based on a large cohort of Chinese preschool children.
    Chan SS; Choi KY; Chan HH
    BMJ Open Ophthalmol; 2024 Feb; 9(1):. PubMed ID: 38388004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
    Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
    Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Changes in Refraction and Biometry of Atropine- and Placebo-Treated Eyes.
    Kumaran A; Htoon HM; Tan D; Chia A
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5650-5. PubMed ID: 26313301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of axial length on full-field and multifocal electroretinograms.
    Sachidanandam R; Ravi P; Sen P
    Clin Exp Optom; 2017 Nov; 100(6):668-675. PubMed ID: 28266057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for progressive myopia in the atropine therapy for myopia study.
    Loh KL; Lu Q; Tan D; Chia A
    Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials.
    Song YY; Wang H; Wang BS; Qi H; Rong ZX; Chen HZ
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):361-8. PubMed ID: 21649523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter Spanish study of atropine 0.01% in childhood myopia progression.
    Pérez-Flores I; Macías-Murelaga B; Barrio-Barrio J;
    Sci Rep; 2021 Nov; 11(1):21748. PubMed ID: 34741059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year results of atropine 0.01% efficacy in the myopia control in a European population.
    Moriche-Carretero M; Revilla-Amores R; Gutiérrez-Blanco A; Moreno-Morillo FJ; Martinez-Perez C; Sánchez-Tena MÁ; Alvarez-Peregrina C
    Br J Ophthalmol; 2024 May; 108(5):715-719. PubMed ID: 37268328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
    Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world outcomes of low-dose atropine therapy on myopia progression in an Australian cohort during the COVID-19 pandemic.
    Usmani E; Callisto S; Chan WO; Taranath D
    Clin Exp Ophthalmol; 2023 Nov; 51(8):775-780. PubMed ID: 37648227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.